Fortaleza Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $206K | Sell |
1,595
-721
| -31% | -$93.1K | 1.67% | 5 |
|
|
2018
Q1 | $239K | Hold |
2,316
| – | – | 1.45% | 18 |
|
|
2017
Q4 | $198K | Hold |
2,316
| – | – | 1.24% | 32 |
|
|
2017
Q3 | $197K | Hold |
2,316
| – | – | 0.36% | 86 |
|
|
2017
Q2 | $175K | Hold |
2,316
| – | – | 0.33% | 87 |
|
|
2017
Q1 | $153K | Hold |
2,316
| – | – | 0.31% | 104 |
|
|
2016
Q4 | $147K | Hold |
2,316
| – | – | 0.31% | 95 |
|
|
2016
Q3 | $147K | Hold |
2,316
| – | – | 0.21% | 92 |
|
|
2016
Q2 | $172K | Sell |
2,316
-1,187
| -34% | -$88.2K | 0.14% | 73 |
|
|
2016
Q1 | $234K | Hold |
3,503
| – | – | 0.15% | 77 |
|
|
2015
Q4 | $237K | Sell |
3,503
-80
| -2% | -$5.41K | 0.14% | 83 |
|
|
2015
Q3 | $191K | Buy |
3,583
+1,267
| +55% | +$67.5K | 0.13% | 109 |
|
|
2015
Q2 | $146K | Buy |
+2,316
| New | +$146K | 0.09% | 141 |
|